Although specific mutations of the p53 protein have been described in approximately 50% of human cancers, a disruption of wild-type p53 transcriptional activity can independently contribute to tumourgenesis in other cancer types (Chene, 2004; Haupt and Haupt, 2004; Tovar et al, 2006). Here, TP53 is linked to cancer.